Estimating the need for antiretroviral treatment and an assessment of a simplified HIV/AIDS case definition in rural Malawi

AIDS

Volumn 21, Issue SUPPL. 6, 2007, Pages

  McGrath, Nuala ^a   Kranzer, Katharina ^a   Saul, Jacqueline ^a   Crampin, Amelia C ^a,b   Malema, Simon ^b   Kachiwanda, Lackson ^b   Zaba, Basia ^a   Jahn, Andreas ^a   Fine, Paul E M ^a   Glynn, Judith R ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b KARONGA PREVENTION STUDY   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CHECKLIST; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; COUNSELING; DEMOGRAPHY; FEMALE; FIELD STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTERVIEW; MALAWI; MALE; MEDICAL CARE; OUTPATIENT DEPARTMENT; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; RURAL AREA; SENSITIVITY AND SPECIFICITY; STAGING; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; ELIGIBILITY DETERMINATION; EPIDEMIOLOGIC METHODS; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HIV INFECTIONS; HUMANS; MALAWI; MALE; MIDDLE AGED; PREVALENCE; RURAL HEALTH;

EID: 36349015384     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000299417.69432.65     Document Type: Conference Paper

References (26)

1. Diaz T, Loth G, Whitworth J, Sutherland D. Surveillance methods to monitor the impact of HIV therapy programmes in resource-constrained countries. AIDS 2005; 19 (Suppl. 2):S31-S37.
2. UNAIDS. Guidelines on construction of core indicators. Geneva: UNAIDS; 2005.
3. Spectrum policy modelling system (computer program), version 2.37Beta1. Futures Inst. Ct. USA 2005.
4. White RG, Vynnycky E, Glynn JR, Crampin AC, Jahn A, Mwaungulu F, et al. HIV epidemic trend and antiretroviral treatment need in Karonga District, Malawi. Epidemiol Infect 2007; 135 (6):922-932.
5. UNAIDS/WHO. Estimation and projection package (computer program), version 2.0b. Geneva: UNAIDS/WHO; 2005.
6. Libamba E, Makombe S, Mhango E, de Ascurra TO, Limbambala E, Schouten EJ, et al. Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi. Bull WHO 2006; 84:320-326.
7. Harries AD, Gomani P, Teck R, de Teck OA, Bakali E, Zachariah R, et al. Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi model. Trans R Soc Trop Med Hyg 2004; 98:695-701.
8. Harries AD, Schouten EJ, Makombe SD, Libamba E, Neufville HN, Some E, et al. Ensuring uninterrupted supplies of antiretroviral drugs in resource-poor settings: an example from Malawi. Bull WHO 2007; 85:152-155.
9. Libamba E, Makombe SD, Harries AD, Schouten EJ, Yu JK, Pasulani O, et al. Malawi's contribution to "3 by 5": achievements and challenges. Bull WHO 2007; 85:156-160.
10. Libamba E, Makombe S, Harries AD, Chimzizi R, Salaniponi FM, Schouten EJ, et al. Scaling up antiretroviral therapy in Africa: learning from tuberculosis control programmes - the case of Malawi. Int J Tuberc Lung Dis 2005; 9:1062-1071.
11. Malawi Ministry of Health. Guidelines for the use of antiretroviral therapy in Malawi, 2nd ed. Lilongwe: Malawi Ministry of Health; 2006.
12. WHO. Case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva: WHO; 2006.
13. WHO. Towards universal access. Scaling up priority HIV/AIDS interventions in the health sector. Progress report. Geneva: WHO; 2007.
14. Jahn A, Crampin AC, Glynn JR, Mwinuka V, Mwafilaso J, Mwaiyeghele E, et al. Evaluation of a village-informant driven demographic surveillance system in Karonga, Northern Malawi. Demograph Res 2007; 16:219-248.
15. Harries AD, Schouten EJ, Libamba E. Scaling up antiretroviral treatment in resource-poor settings. Lancet 2006; 367:1870-1872.
16. Crampin AC, Glynn JR, Ngwira BM, Mwaungulu FD, Ponnighaus JM, Warndorff DK, et al. Trends and measurement of HIV prevalence in northern Malawi. AIDS 2003; 17:1817-1825.
17. Morgan D, Maude GH, Malamba SS, Okongo MJ, Wagner HU, Mulder DW, et al. HIV-1 disease progression and AIDS-defining disorders in rural Uganda. Lancet 1997; 350:245-250.
18. Joint United Nations Programme on HIV/AIDS. Monitoring the declaration of commitment on HIV/AIDS: guidelines on construction of core indicators. ISBN 92-9173-238-9:25-26. 2003. Geneva: UNAIDS; 2003.
19. Fryland M, Chaillet P, Zachariah R, Barnaba A, Bonte L, Andereassen R, et al. The Partec CyFlow Counter could provide an option for CD4+T-cell monitoring in the context of scalingup antiretroviral treatment at the district level in Malawi. Trans R Soc Trop Med Hyg 2006; 100:980-985.
20. Zijenah LS, Kadzirange G, Madzime S, Borok M, Mudiwa C, Tobaiwa O, et al. Affordable flow cytometry for enumeration of absolute CD4+ T-lymphocytes to identify subtype C HIV-1 infected adults requiring antiretroviral therapy (ART) and monitoring response to ART in a resource-limited setting. J Transl Med 2006; 4:33.
21. Balakrishnan P, Dunne M, Kumarasamy N, Crowe S, Subbulakshmi G, Ganesh AK, et al. An inexpensive, simple, and manual method of CD4 T-cell quantitation in HIV-infected individuals for use in developing countries. J Acquir Immune Defic Syndr 2004; 36:1006-1010.
22. Tassie JM, Marquardt T, Damisoni H, Odhiambo OD, Mulemba M, Szumilin E, et al. Indirect markers to initiate highly active antiretroviral therapy in a rural African setting. AIDS 2004; 18:1226-1228.
23. Scarborough M, Gordon SB, French N, Phiri C, Musaya J, Zijlstra EE. Grey nails predict low CD4 cell count among untreated patients with HIV infection in Malawi. AIDS 2006; 20:1415-1417.
24. Diomande FV, Bissagnene E, Nkengasong JN, Maurice C, Monga B, Laga M, et al. The most efficient use of resources to identify those in need of antiretroviral treatment in Africa: empirical data from Cote d'Ivoire's Drug Access Initiative. AIDS 2003; 17 (Suppl. 3):S87-S93.
25. Goldie SJ, Yazdanpanah Y, Losina E, Weinstein MC, Anglaret X, Walensky RP, et al. Cost-effectiveness of HIV treatment in resource-poor settings - the case of Cote d'Ivoire. N Engl J Med 2006; 355:1141-1153.
26. Martinson N. Does WHO clinical stage reliably predict who should receive ART treatment? In: Third International AIDS Society Conference on HIV Pathogenesis and Treatment. Abstract no We F00304 Rio de Janeiro, Brazil, 24-27 July 2005.